1. Home
  2. INMD vs HQH Comparison

INMD vs HQH Comparison

Compare INMD & HQH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INMD
  • HQH
  • Stock Information
  • Founded
  • INMD 2008
  • HQH 1986
  • Country
  • INMD Israel
  • HQH United States
  • Employees
  • INMD N/A
  • HQH N/A
  • Industry
  • INMD Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • HQH Finance Companies
  • Sector
  • INMD Health Care
  • HQH Finance
  • Exchange
  • INMD Nasdaq
  • HQH Nasdaq
  • Market Cap
  • INMD 887.0M
  • HQH 826.8M
  • IPO Year
  • INMD 2019
  • HQH N/A
  • Fundamental
  • Price
  • INMD $13.28
  • HQH $15.30
  • Analyst Decision
  • INMD Hold
  • HQH
  • Analyst Count
  • INMD 6
  • HQH 0
  • Target Price
  • INMD $17.56
  • HQH N/A
  • AVG Volume (30 Days)
  • INMD 1.1M
  • HQH 183.8K
  • Earning Date
  • INMD 07-31-2025
  • HQH 01-01-0001
  • Dividend Yield
  • INMD N/A
  • HQH 11.56%
  • EPS Growth
  • INMD 8.69
  • HQH N/A
  • EPS
  • INMD 2.29
  • HQH 1.09
  • Revenue
  • INMD $392,408,000.00
  • HQH N/A
  • Revenue This Year
  • INMD $0.16
  • HQH N/A
  • Revenue Next Year
  • INMD $4.84
  • HQH N/A
  • P/E Ratio
  • INMD $5.79
  • HQH $15.24
  • Revenue Growth
  • INMD N/A
  • HQH N/A
  • 52 Week Low
  • INMD $13.16
  • HQH $14.31
  • 52 Week High
  • INMD $19.85
  • HQH $17.94
  • Technical
  • Relative Strength Index (RSI)
  • INMD 33.86
  • HQH 43.45
  • Support Level
  • INMD $13.16
  • HQH $15.28
  • Resistance Level
  • INMD $13.67
  • HQH $15.82
  • Average True Range (ATR)
  • INMD 0.40
  • HQH 0.23
  • MACD
  • INMD -0.09
  • HQH -0.02
  • Stochastic Oscillator
  • INMD 7.23
  • HQH 16.85

About INMD InMode Ltd.

InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF and Morpheus8. The majority of its revenue comes from the United States.

About HQH abrdn Healthcare Investors Shares of Beneficial Interest

abrdn Healthcare Investors Formerly Tekla Healthcare Investors is the United States based non-diversified closed-end management investment company. Its objective is to seek long-term capital appreciation by investing in securities of healthcare companies. In addition, the fund seeks to provide regular distribution of realized capital gains. The fund invests in the securities of public and private companies.

Share on Social Networks: